Ganapathy Venugopal

Angel investor in Dublin

Invests in AI

AI is one of the sectors on Ganapathy Venugopal's investor profile, next to InsurTech, Healthcare & Biotech and Digital Health & HealthTech, at early-stage venture. The record holds 2 deals, including Sprink and Xobin.

Email Investor

Email Investor

Credits to line up before an early-stage round

Ganapathy Venugopal backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Sprink
  • Xobin

Investment focus

Backs startups in
Artificial Intelligence, InsurTech, Healthcare & Biotech, Digital Health & HealthTech, SaaS & Enterprise, Consumer & Retail and 11 more
Rounds
Early-stage venture
Profile
Angel investor
Deals on record
2
Based in
Dublin, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Ganapathy Venugopal invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Ganapathy Venugopal's investor profile, together with InsurTech, Healthcare & Biotech and Digital Health & HealthTech. The stages on record are early-stage venture.
Which companies has Ganapathy Venugopal backed?
The record lists 2 deals, including Sprink and Xobin. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Ganapathy Venugopal?
For a company raising an early-stage round, AI Perks lists credits such as Confluent (up to $20,000), Alibaba Cloud (up to Up to $120,000 + 2B Model Studio tokens), Amazon Bedrock (up to $200,000) and Retool (up to $225,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor